Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 106

1.

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC).

Valgimigli M, Garcia Garcia H, Vrijens B, Vranckx P, McFadden EP, Costa F, Pieper K, Vock DM, Zhang M, Van Es GA, Tricoci P, Baber U, Steg G, Montalescot G, Angiolillo DJ, Serruys PW, Farb A, Windecker S, Kastrati A, Colombo A, Feres F, Jüni P, Stone GW, Bhatt DL, Mehran R, Tijssen JGP.

Eur Heart J. 2018 Jul 9. doi: 10.1093/eurheartj/ehy377. [Epub ahead of print]

PMID:
29992264
2.

Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials.

Lee SY, Hong MK, Palmerini T, Kim HS, Valgimigli M, Feres F, Colombo A, Gilard M, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Stone GW.

JACC Cardiovasc Interv. 2018 Mar 12;11(5):435-443. doi: 10.1016/j.jcin.2017.10.015. Epub 2018 Feb 14.

PMID:
29454730
3.

Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Sharma A, Garg A, Elmariah S, Drachman D, Obiagwu C, Vallakati A, Sharma SK, Lavie CJ, Mukherjee D, Waksman R, Stefanini GG, Feres F, Marmur JD, Helft G.

Prog Cardiovasc Dis. 2018 Jan - Feb;60(4-5):500-507. doi: 10.1016/j.pcad.2017.12.003. Epub 2017 Dec 24. Review.

PMID:
29277295
4.

Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis.

Piccolo R, Feres F, Abizaid A, Gilard M, Morice MC, Hong MK, Kim HS, Colombo A, Bhatt DL, Palmerini T, Stone GW, Windecker S, Valgimigli M.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1621-1630. doi: 10.1016/j.jcin.2017.06.001. Review.

5.

DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA.

Feres F, Costa RA, Siqueira D, Costa JR Jr, Chamié D, Staico R, Chaves ÁJ, Abizaid A, Marin-Neto JA, Rassi A Jr, Botelho R, Alves CMR, Saad JA, Mangione JA, Lemos PA, Quadros AS, Queiroga MAC, Cantarelli MJC, Figueira HR.

Arq Bras Cardiol. 2017 Jun;109(1 Suppl 1):1-81. doi: 10.5935/abc.20170111. Review. Portuguese. No abstract available.

6.

Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.

Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Ahn JM, Park SJ, Schüpke S, Kastrati A, Montalescot G, Steg PG, Diallo A, Vicaut E, Helft G, Biondi-Zoccai G, Xu B, Han Y, Genereux P, Bhatt DL, Stone GW.

J Am Coll Cardiol. 2017 Apr 25;69(16):2011-2022. doi: 10.1016/j.jacc.2017.02.029.

7.

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators.

Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5. Review.

PMID:
28290994
8.

Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.

Zuliani Mauro MF, Mangione JA, Costa JR Jr, Costa R, Piva E Mattos LA, Staico R, Feres F, Siqueira D, Sousa A, Abizaid A.

J Invasive Cardiol. 2017 Mar;29(3):76-81.

9.

Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.

Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Sangiorgi D, Biondi-Zoccai G, Généreux P, Angelini GD, Pufulete M, White J, Bhatt DL, Stone GW.

Eur Heart J. 2017 Apr 7;38(14):1034-1043. doi: 10.1093/eurheartj/ehw627. Review.

10.

Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.

Gargiulo G, Windecker S, da Costa BR, Feres F, Hong MK, Gilard M, Kim HS, Colombo A, Bhatt DL, Kim BK, Morice MC, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M.

BMJ. 2016 Nov 3;355:i5483. doi: 10.1136/bmj.i5483. Review.

11.

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.

Giustino G, Chieffo A, Palmerini T, Valgimigli M, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Gilard M, Morice MC, Sawaya F, Sardella G, Genereux P, Redfors B, Leon MB, Bhatt DL, Stone GW, Colombo A.

J Am Coll Cardiol. 2016 Oct 25;68(17):1851-1864. doi: 10.1016/j.jacc.2016.07.760. Epub 2016 Aug 29.

12.

Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.

Sawaya FJ, Morice MC, Spaziano M, Mehran R, Didier R, Roy A, Valgimigli M, Kim HS, Woo Park K, Hong MK, Kim BK, Jang Y, Feres F, Abizaid A, Costa RA, Colombo A, Chieffo A, Giustino G, Stone GW, Bhatt DL, Palmerini T, Gilard M.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):178-189. doi: 10.1002/ccd.26653. Epub 2016 Jul 18.

PMID:
27426936
13.

A Randomized Trial of Creatine-kinase Leak After Rosuvastatin in Elective Percutaneous Coronary Intervention (CLEAR-PCI).

Martins KB, Mattos LA, Sousa AG, Sousa JE, Abzaid A, Feres F, de Ribamar JC Jr, Staico R, Costa RA, Chaves AJ.

J Interv Cardiol. 2015 Aug;28(4):339-47. doi: 10.1111/joic.12209. Epub 2015 Jun 18.

PMID:
26086603
14.

Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.

Palmerini T, Sangiorgi D, Valgimigli M, Biondi-Zoccai G, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Mariani A, Della Riva D, Genereux P, Leon MB, Bhatt DL, Bendetto U, Rapezzi C, Stone GW.

J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102. doi: 10.1016/j.jacc.2014.12.046. Review.

15.

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.

Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, Abizaid A, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Genereux P, Bhatt DL, Orlandi C, De Servi S, Petrou M, Rapezzi C, Stone GW.

Lancet. 2015 Jun 13;385(9985):2371-82. doi: 10.1016/S0140-6736(15)60263-X. Epub 2015 Mar 14. Review.

PMID:
25777667
16.

[Guidelines of Sociedade Brasileira de Cardiologia for Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (II Edition, 2007) 2013-2014 Update].

Nicolau JC, Timerman A, Marin-Neto JA, Piegas LS, Barbosa CJ, Franci A, Avezum A Jr, Carvalho AC, Markman Filho B, Polanczyk CA, Rochitte CE, Serrano Júnior CV, Precoma DB, Silva Junior DG, Albuquerque DC, Stefanini E, Knobel E, Jatene FB, Feres F, Morcerf FA, Ganem F, Lima Filho FA, Feitosa Filho GS, Ferreira JF, Meneghetti JC, Saraiva JF, Silva LS, Maia LN, Baracioli LM, Lisboa LA, Dallan LA, Bodanese LC, Andrade MD, Oliveira Júnior M, Dutra OP, Coelho OR, Leães PE, Albuquerque PF, Lemos P, Kalil R, Costa RV, Esporcate R, Marino RL, Botellho RV, Meneghelo RS, Sprovieri SR, Timerman S, Mathias Júnior W; Sociedade Brasileira de Cardiologia.

Arq Bras Cardiol. 2014 Mar;102(3 Suppl 1):1-61. Portuguese. No abstract available.

17.

Dual antiplatelet therapy after stent implantation--reply.

Feres F, Costa RA, Bhatt DL.

JAMA. 2014 Apr 9;311(14):1446-7. doi: 10.1001/jama.2014.2107. No abstract available.

PMID:
24715082
18.

Association between sex hormone-binding globulin (SHBG) and metabolic syndrome among men.

Sá EQ, Sá FC, Oliveira KC, Feres F, Verreschi IT.

Sao Paulo Med J. 2014;132(2):111-5.

19.

Left main percutaneous coronary intervention: growing in maturity.

Feres F, Costa RA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1261-2. doi: 10.1016/j.jcin.2013.10.008. No abstract available.

20.

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB 3rd, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ Jr, Nicolela EL Jr, Perin MA, Devito FS, Labrunie A, Salvadori D Jr, Gusmão M, Staico R, Costa JR Jr, de Castro JP, Abizaid AS, Bhatt DL; OPTIMIZE Trial Investigators.

JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.

PMID:
24177257

Supplemental Content

Support Center